GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shield Therapeutics PLC (OTCPK:SHIEF) » Definitions » Cyclically Adjusted PB Ratio

Shield Therapeutics (Shield Therapeutics) Cyclically Adjusted PB Ratio : 0.14 (As of Jun. 08, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Shield Therapeutics Cyclically Adjusted PB Ratio?

As of today (2024-06-08), Shield Therapeutics's current share price is $0.022. Shield Therapeutics's Cyclically Adjusted Book per Share for the fiscal year that ended in Dec23 was $0.16. Shield Therapeutics's Cyclically Adjusted PB Ratio for today is 0.14.

The historical rank and industry rank for Shield Therapeutics's Cyclically Adjusted PB Ratio or its related term are showing as below:

SHIEF' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.1   Med: 0.17   Max: 0.58
Current: 0.16

During the past 10 years, Shield Therapeutics's highest Cyclically Adjusted PB Ratio was 0.58. The lowest was 0.10. And the median was 0.17.

SHIEF's Cyclically Adjusted PB Ratio is ranked better than
93.53% of 742 companies
in the Drug Manufacturers industry
Industry Median: 1.875 vs SHIEF: 0.16

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Shield Therapeutics's adjusted book value per share data of for the fiscal year that ended in Dec23 was $0.019. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $0.16 for the trailing ten years ended in Dec23.

Shiller PE for Stocks: The True Measure of Stock Valuation


Shield Therapeutics Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Shield Therapeutics's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shield Therapeutics Cyclically Adjusted PB Ratio Chart

Shield Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.53

Shield Therapeutics Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 0.53

Competitive Comparison of Shield Therapeutics's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Shield Therapeutics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shield Therapeutics's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shield Therapeutics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Shield Therapeutics's Cyclically Adjusted PB Ratio falls into.



Shield Therapeutics Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Shield Therapeutics's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=0.022/0.16
=0.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shield Therapeutics's Cyclically Adjusted Book per Share for the fiscal year that ended in Dec23 is calculated as:

For example, Shield Therapeutics's adjusted Book Value per Share data for the fiscal year that ended in Dec23 was:

Adj_Book=Book Value per Share/CPI of Dec23 (Change)*Current CPI (Dec23)
=0.019/130.5000*130.5000
=0.019

Current CPI (Dec23) = 130.5000.

Shield Therapeutics Annual Data

Book Value per Share CPI Adj_Book
201412 -0.950 99.900 -1.241
201512 -0.248 100.400 -0.322
201612 0.537 102.200 0.686
201712 0.465 105.000 0.578
201812 0.428 107.100 0.522
201912 0.349 108.500 0.420
202012 0.341 109.400 0.407
202112 0.249 114.700 0.283
202212 0.025 125.300 0.026
202312 0.019 130.500 0.019

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Shield Therapeutics  (OTCPK:SHIEF) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Shield Therapeutics Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Shield Therapeutics's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Shield Therapeutics (Shield Therapeutics) Business Description

Traded in Other Exchanges
Address
Northern Design Centre, Baltic Business Quarter, Gateshead Quays, Newcastle, GBR, NE8 3DF
Shield Therapeutics PLC is a specialty pharmaceutical company focused on the development and commercialization of late-stage, hospital-focused pharmaceuticals which address areas of high unmet medical need. The company's operating segments are based on key products including Accrufer/Feraccru, used as a novel oral treatment for iron deficiency anemia in patients, which is commercially available, and PT20 used in treating hyperphosphatemia, which is in its last stage of completion. The company generates maximum revenue from Feraccru segment.

Shield Therapeutics (Shield Therapeutics) Headlines

From GuruFocus